image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
c4175b43e2f9a1e008a5f0febd20e7cbed6a346ce32d1d6712716ff9cb83e061.png | complex | <table><tr><td></td><td colspan="3">Yale University cohort</td><td></td></tr><tr><td>Variable</td><td>No. of patients (%) (n = 651)</td><td>HR</td><td>95% CI</td><td><i>P</i>*</td></tr><tr><td>Age at diagnosis</td><td>645 (99.1)</td><td>0.999</td><td>0.988-1.009</td><td>0.890</td></tr><tr><td> Unknown/missing</td><td>6... |
6187edbb2d4504573a032357c49b973b755b6b2c38f85c5da358d7e41d7a75e6.png | complex | <table><tr><td>Study groups</td><td>N</td><td>Mean</td><td>SD</td><td>P-value</td></tr><tr><td>Live Demonstration</td><td>26</td><td>6.69</td><td>1.4</td><td rowspan="3">.864*</td></tr><tr><td>Procedural Video</td><td>23</td><td>6.78</td><td>2.1</td></tr><tr><td>Total</td><td>49</td><td>6.73</td><td>1.8</td></tr></tabl... |
9de0eb28e3611efc1f374db62bc0c3c94b28d27dc020ec8cf6c4f8217f621250.png | simple | <table><tr><td>Resource</td><td>Connectivity Comments</td><td>Reference</td></tr><tr><td>BindingDB</td><td>Comprehensive ligand-target database, we now cross-reference selected patent extractions from this source</td><td>(43)</td></tr><tr><td>ChEMBL and UniChem</td><td>Inclusion of our target protein pointers and a ChE... |
081e9128359490aef10a1615fa9b5e50f32b2b55afe343c80ce0cd6ab5b1794e.png | simple | <table><tr><td>Chr</td><td>MS</td><td>AI</td><td>DA</td><td>KA</td><td>NY</td><td>SNP</td><td>AI</td><td>DA</td><td>KA</td></tr><tr><td>1</td><td>D01S0023</td><td>21.60</td><td>41.65</td><td>12.18</td><td>14.59</td><td>C01R0052</td><td>21.53</td><td>47.08</td><td>13.43</td></tr><tr><td>3</td><td>D03S0127</td><td>30.32<... |
2d2dfcb6777cfc1889f42a3460c3c27a488331061bba9f95dbf3a81bf58f3c07.png | complex | <table><tr><td>Multivariate Cox regression</td><td></td><td></td><td></td><td></td></tr><tr><td>Factor</td><td><i>P</i></td><td>HR</td><td colspan="2">95% CI</td></tr><tr><td></td><td></td><td></td><td>Lower</td><td>Upper</td></tr><tr><td>INSS Stage (1-3, 4S vs 4)</td><td>0.002</td><td>7.15</td><td>2.08</td><td>24.64</... |
2d2b63092d79ee33c44baba7b50c861791200d0fc9d473b2fd3c068df2f59b5f.png | complex | <table><tr><td rowspan="2"> </td><td rowspan="2"> </td><td colspan="2">All</td><td colspan="2">Control group</td><td colspan="2">Intervention group</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Study group</td><td> </td><td>604</td><td>100</td><td>242</td><td>40.1</td><td>362</td... |
b83d87b7c7806b92640e600d9dafc301eaf30f6759874d06fe25a962f46e9737.png | complex | <table><tr><td>(n = 593)</td><td>One-factor model</td><td colspan="2">Two-factor model</td><td colspan="3">Three-factor model</td></tr><tr><td>Sensation</td><td>Sensitivity</td><td>Pleasant</td><td>Unpleasant</td><td>Pleasant</td><td>Unpleasant</td><td>Buzz</td></tr><tr><td>Cough</td><td>0.27</td><td>−0.16</td><t... |
98463272a7b8a18457595e6f6ded1fbb57cf646181c0d2ec675e696468dfc680.png | simple | <table><tr><td>Author (year) of published PCR assay</td><td>PCR target</td><td>PCR technique</td><td>Amplicon size (bp)</td><td>Zika virus lineage analytical</td><td>Zika virus lineage field</td><td>No. of human patients tested in studies</td><td>Sample types positive in field</td></tr><tr><td>Lanciotti et al. (2008)<s... |
77849470f34ab849a00e615494c9a2958424d06465c7ea17d42063007e6d0689.png | simple | <table><tr><td>Explanatory variable</td><td>OR</td><td>95%CI</td><td>P value</td></tr><tr><td>Presence of C allele in genotype at rs3173798 (Yes=1, No=0)</td><td>0.28</td><td>0.12–0.67</td><td>0.0043</td></tr><tr><td>Age (years)</td><td>0.97</td><td>0.93–1.02</td><td>0.27</td></tr><tr><td>Gender (female=1, ... |
07bef33c2cc04db0c30aece8ad26d1d5d0ae5e7fab3d704914055a1285ae14b1.png | complex | <table><tr><td rowspan="3">Age group</td><td colspan="6">1990</td><td colspan="6">2015</td></tr><tr><td colspan="3">Global</td><td colspan="3">Brazil</td><td colspan="3">Global</td><td colspan="3">Brazil</td></tr><tr><td>Rate</td><td colspan="2">95% UI</td><td>Rate</td><td colspan="2">95% UI</td><td>Rate</td><td colspa... |
19388fced408bffa4c9c9c0022ab85a14f10358cac4aab545cc730ec35257e68.png | complex | <table><tr><td></td><td colspan="3">The GP and the patient are a well-functioning team (<i>n</i> = 270)</td></tr><tr><td></td><td>OR</td><td>95% CI</td><td><i>p</i>-value</td></tr><tr><td colspan="4">Age</td></tr><tr><td> 16–39</td><td>1.30</td><td>0.63–2.71</td><td>0.471</td></tr><tr><td> 40–59<sup>a... |
e362f246ab0037323067d9923df79a0a20fd614831f87c2346ca66f9ca052304.png | simple | <table><tr><td>Age group</td><td>Patients, no.</td><td>%</td></tr><tr><td>Infant</td><td>9</td><td>0</td></tr><tr><td>Child</td><td>12</td><td>0</td></tr><tr><td>Adolescent</td><td>4</td><td>0</td></tr></table> |
f124df5d8fddbc0fa6b32d2cdc4da06b58d2109f04a63f60116ee797191e528c.png | simple | <table><tr><td></td><td>Calcium score zero (<i>N</i> = 239)</td><td>Calcium score abnormal (<i>N</i> = 103)</td><td><i>P</i> value</td></tr><tr><td>Age, years</td><td>47.0 (6.4)</td><td>52.6 (6.6)</td><td><0.001</td></tr><tr><td>Gender, female %</td><td>66 (27.6)</td><td>11 (10.6)</td><td></td></tr><tr><td>Height, c... |
432f2974ff0e323790e429512471a58a03f4a38e5f0e49a80f57f08608f7ed16.png | complex | <table><tr><td></td><td colspan="3">Week 1<sup>A</sup></td><td colspan="3">Week 2<sup>A</sup></td><td colspan="2"><i>P</i></td></tr><tr><td></td><td>Control</td><td>Canola</td><td>Sunflower</td><td>Control</td><td>Canola</td><td>Sunflower</td><td>Trt<sup>B</sup></td><td>Trt*wk<sup>C</sup></td></tr><tr><td>Cows (n)</td>... |
baad41387d9d9bb0c955d600550056153811b0418b38b66115512f5dfb194530.png | simple | <table><tr><td>Patient</td><td>Breed</td><td>Age</td><td>Sex</td><td>Activity</td><td>Laminitis Stage</td><td>Venography Stage</td><td>Prognosis (before Treatment)</td></tr><tr><td>CASE 1</td><td>QUARTER HORSE</td><td>18</td><td>F</td><td>MARE</td><td>BILATERAL ROTATION</td><td>4</td><td>POOR</td></tr><tr><td>CASE 2</t... |
e171d0a2ee782d9982764d34e0670ccd4c7929693ebf6fdf98cf0609f5bee55d.png | simple | <table><tr><td>Scales</td><td>N</td><td>Mean</td><td>SD</td><td>Min.</td><td>Q1</td><td>Median</td><td>Q3</td><td>Max.</td><td><i>P</i>-value</td></tr><tr><td>HSQS/EPM (1st administration)</td><td>86</td><td>74.6</td><td>4.6</td><td>60.0</td><td>72.0</td><td>75.5</td><td>78.0</td><td>86.4</td><td>0.005<sup>1</sup></td>... |
384c4efa3ab1654da840069f186923ee5e400fd50219d3264ca49dafc756a8df.png | complex | <table><tr><td colspan="2"></td><td colspan="4">Patients’ characteristics</td></tr><tr><td>Gender</td><td></td><td>Age</td><td>Weight</td><td>Height</td><td>BMI</td></tr><tr><td rowspan="5">Females</td><td><i>n</i></td><td>66</td><td>66</td><td>66</td><td>66</td></tr><tr><td>Mean (SD)</td><td>62.8 (9.28)</td><td>... |
7af61e0fba35c02ef730636d2417ade80ce72212c6233cc51789179cee20affa.png | complex | <table><tr><td rowspan="2">Clinical and epidemiological characteristic</td><td colspan="2">Another malignancy</td><td rowspan="2"><i>P</i></td></tr><tr><td>Postiodine<i>N</i> = 7 (46.66%)</td><td>Preiodine<i>N</i> = 8 (53.33%)</td></tr><tr><td>Males <i>N</i> (%)</td><td>4 (57.14)</td><td>3 (37.5)</td><td>0.6193</td></t... |
8a8a2ee59494752736aa72444ff5616f3de3c2c435b2f46f904d193213222c05.png | complex | <table><tr><td colspan="2">CONSENSUS CRITERIA FOR DEMENTIA CASE ASCERTAINMENT</td></tr><tr><td>PROBABLE DEMENTIA</td><td>POSSIBLE DEMENTIA</td></tr><tr><td>ANY of the following (without opposing evidence from same/other source):- dementia diagnosis on death certificate (any part)- dementia diagnosed on clinical review ... |
2a74453c80b60f5b2d34a65f6eb9052d58f2693e7e7a509703d041f76d19526a.png | simple | <table><tr><td>Isolate</td><td>ST <sup>1</sup></td><td>CC <sup>2</sup></td><td>LIPI1</td><td>LIPI3</td><td>LIPI4</td><td>InlA </td><td>SSI-1</td></tr><tr><td>MQ130026</td><td>ST-1</td><td>CC1</td><td>+ <sup>3</sup></td><td>+</td><td>− <sup>4</sup></td><td>+ <sup>5</sup></td><td>−</td></tr><tr><td>L970</td><... |
46ee1776e9ce2f096ea20d70c48ad5696654006da7f728f6cc64c53724fa58a2.png | simple | <table><tr><td>Variable</td><td>All patients (n = 102)</td><td>Group 1 (n = 48)</td><td>Group 2 (n = 54)</td></tr><tr><td>FEV<sub>1</sub></td><td>50 (0.84 [0.70;0.98])<sup>a</sup></td><td>31 (1.08 [0.70;1.45])<sup>a</sup></td><td>18 (0.67 [0.46;0.88])<sup>a</sup></td></tr><tr><td>BR</td><td>12 (−0.62 [−0.82... |
15b7a6fbbee3049a5e8e6f31d2dde1cfde7134156e5f788a232b5f3093b998cd.png | simple | <table><tr><td>(1) Memory</td><td>(2) Language</td><td>(3) Perceptual</td><td>(4) Visuospatial</td><td>(5) Calculation</td></tr><tr><td>Rey immediate recall</td><td>Semantic fluency </td><td>VOSP X-detection</td><td>Barrage</td><td>Additions</td></tr><tr><td>Rey delayed recall</td><td>Phonological fluency</td><td>Bento... |
149db96c33c1f66aa82e37de920bbb8f6bd8c9e307e9c47be019c539684e9ec3.png | complex | <table><tr><td rowspan="3" colspan="2">Change in response variables</td><td colspan="6">Explanatory variables</td></tr><tr><td rowspan="2">Dose of tofacitinib<sup>a</sup></td><td colspan="5">Lymphocyte sub-populations</td></tr><tr><td>T (CD3<sup>+</sup>)</td><td>T<sub>H</sub>(CD3<sup>+</sup>/CD4<sup>+</sup>)</td><td>T<... |
8d2eb63b44adbef2f2e21434c3caf7c0e32e9a6de38db60084d0c4dbf9db86b1.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">IOP (mmHg)</td><td></td><td colspan="2">OPP (mmHg)</td><td></td></tr><tr><td>Affected Eye</td><td>Unaffected Eye</td><td><i>P</i> value*</td><td>Affected Eye</td><td>Unaffected Eye</td><td><i>P</i> value*</td></tr><tr><td>T1</td><td>16.6 ± 3.4 (10.5–23.3)</td><... |
b54a3d038c17fa9edd63aa6bddbe672346935860bbb66497556aa40c4182852a.png | simple | <table><tr><td>#</td><td>Nugget Topic</td><td>Nugget Content (3rd ed.)</td></tr><tr><td>6.</td><td><i>Pharmacological management of neuropathic pain</i></td><td>Use a step-wise evidence-based protocol for the management of neuropathic pain in SCI, and review pain management annually.</td></tr><tr><td>10.</td><td><i>Die... |
393be005d439d22c4e3dbdccfc61de8f227335602f79123f14fa4e88de01798f.png | simple | <table><tr><td>CNTs</td><td>Hydroxyl Content % (<i>w</i>/<i>w</i>)</td><td>Carboxyl Content % (<i>w</i>/<i>w</i>)</td><td>Diameter (nm)</td><td>Length (μm)</td><td>SSA (m<sup>2</sup>/g)</td><td>PC Sets</td><td>PC Names</td></tr><tr><td>F1</td><td>_</td><td>_</td><td>10–20</td><td>30–100</td><td>>165... |
21e9a99b219c6e866c53e7ae2d8e8145f34627e216bf6ec561dc5b95e6ffa946.png | complex | <table><tr><td rowspan="3"></td><td colspan="9">Median MET-min/week (IQR)</td></tr><tr><td colspan="2">Erectile dysfunction</td><td rowspan="2"><i>p</i> value</td><td colspan="2">Premature ejaculation</td><td rowspan="2"><i>p</i> value</td><td colspan="2">Libido</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>Absen... |
c0be9cb44095a3c469a1d0a15d19de4bbaf0bd418806ba7dabeb637f725a7c91.png | simple | <table><tr><td>Subjects</td><td>Age (years)</td><td>Odor threshold (score/16)</td><td>Odor discrimination (score/16)</td><td>Multiple choice identification (score/16)</td><td>TDI composite score (score/48)</td><td>Retronasal testing (score/20)</td></tr><tr><td>EB1</td><td>21</td><td>7.3</td><td>15</td><td>10</td><td>32... |
2e6e7d2429967eb49d0c4d4d40f71e3a1b2a42b7984172719129b925841ce0a7.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="6">Number of lethality (%)</td></tr><tr><td colspan="2"><i>Tribolium castaneum</i></td><td colspan="2"><i>Rhyzopertha dominica</i></td><td colspan="2"><i>Callosbruchus analis</i></td></tr><tr><td>Crude extract</td><td>0.33 ± 0.57</td><td>3.3 ± 5.7</td><td>0</... |
0260fff33957cd5e4cea168bd70114418f5ddb64af363a35a1ffa5cd6379242c.png | simple | <table><tr><td></td><td>Sarcoidosis<i>N</i> = 17</td><td>Control disease<i>N</i> = 11</td><td>Tuberculosis<i>N</i> = 8</td><td><i>P</i> Value</td></tr><tr><td>Age, mean ± SD (years)</td><td>53.12 ± 7.41</td><td>53.55 ± 12.75</td><td>45.13 ± 20.73</td><td>0.3013</td></tr><tr><td>Male/female ratio</td... |
45004dd263b0a6c8546d91dd99324c5516790b70746bd61c7bf90816ae929d3a.png | simple | <table><tr><td>Comet class</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>TCS</td></tr><tr><td>Exposed group</td><td>21.6 ± 13.4</td><td>32.5 ± 14.2</td><td>15.8 ± 11.9</td><td>11.3 ± 9.9</td><td>18.7 ± 9.4</td><td>173.2 ± 50.1*</td></tr><tr><td>Control group</td><td>67.7 ±... |
99f50d74bb134edb5fe9723d214d32dc2d5233b0171e3bd1575c44a08121ff1b.png | simple | <table><tr><td>Cost<sup>a</sup></td><td>Argentina</td><td>Brazil</td><td>Chile</td><td>Colombia</td><td>Ecuador</td><td>Mexico</td><td>Peru</td></tr><tr><td>< 1</td><td>Rivaroxavan</td><td>Rivaroxavan</td><td>Rivaroxavan</td><td>Rivaroxavan</td><td>–</td><td>Rivaroxavan</td><td>Rivaroxavan</td></tr><tr><td>1&#... |
aa45822eae4371a9168ebbba063a7dcb62cd5b1e3c3ec28c80a2d77d5fb031b3.png | complex | <table><tr><td>Origin</td><td>Methods</td><td>Dysregulated miRNAs</td><td>Study Details</td></tr><tr><td colspan="4"><i>Aortic stenosis</i></td></tr><tr><td>Aortic valve leaflets [24]</td><td>Microarray qPCR</td><td>Downregulated: 26a, 30b, 195</td><td>9 patients with BAV (AS vs. aortic insufficiency requiring AVR)</td... |
12dc63f046a63ee8c34334c08b8b7182d947bfd99503f2bfea365426324380cd.png | simple | <table><tr><td>Variable</td><td>Base case value</td><td>Distribution</td><td>Parameters</td><td>Source/Notes</td></tr><tr><td>Probability of sustained virological response (SVR) in control group</td><td>0.02%</td><td>Beta</td><td>Alpha = 1 Beta = 559</td><td>Koretz et al.[23]</td></tr><tr><td>Log risk ratio (SVR: inter... |
5787aa8eff1d474851080ee9af6c0150ccd83b5ed24a23da92091062d1e946c8.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">CI session</td><td colspan="3">MDMA + CI session</td><td colspan="3"><i>F</i> value</td></tr><tr><td>T1</td><td>T2</td><td>T3</td><td>T1</td><td>T2</td><td>T3</td><td>Session</td><td>Time</td><td>Session × Time</td></tr><tr><td>TPAS—active</td><td>16.10 (6.04)<... |
728c3cef161dd94d5a3c6980570a7d68ba8e832cd778c11708141e1dc79ad778.png | complex | <table><tr><td>Tx-type; Cause of Death</td><td>< 12 months</td><td>> 12 months</td><td><i>p</i>-value</td></tr><tr><td>Total: 278</td><td></td><td></td><td></td></tr><tr><td colspan="4">SLTx (<i>n</i> = 97)</td></tr><tr><td> Total number of deaths</td><td>17</td><td>51</td><td>0.158</td></tr><tr><td> Death from O... |
8f633e6dab81206083faaa3c3a704cbb871b7f5eb918d651332b94ce10bf08dc.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Bivariate linear regression</td><td colspan="2">Multivariate linear regression</td></tr><tr><td>Coefficient (95 % CI)</td><td><i>P</i>-value</td><td>Coefficient (95 % CI)</td><td><i>P</i>-value</td></tr><tr><td>Male gender</td><td>5.707 (2.887, 8.526)</td><td><... |
04ee76968c76d4f5db34842a59b5c8b72728dcf16b7edbe54b7af872935d8a7c.png | complex | <table><tr><td> </td><td>Total (<i>n</i> = 370)</td><td>Qi deficiency of spleen and kidney (<i>n</i> = 273)</td><td>Deficiency of both qi and yin (<i>n</i> = 66)</td><td>Other types (<i>n</i> = 31)</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>32 (27–42)</td><td>33 (27–42)</td><td>29 (25–... |
6725e762f54bdd3222790dc6795adfaf3a1ff9c78792d1ea3a867cdc4720208a.png | complex | <table><tr><td>Growth year</td><td>Thickness/μm</td><td>Sheet name</td><td>Brix degree/%</td><td>Acid value/%</td><td>Peel color/a value</td></tr><tr><td rowspan="3">2004</td><td rowspan="3">30</td><td>unmulched</td><td>9.0 ± 0.3</td><td>0.68 ± 0.05</td><td>21.7 ± 1.0</td></tr><tr><td>MS-3,7,0</td><... |
e281ae665d1292ae93651df0d64ad027e0b0bbf6733e7accf0fcc72f09ebe162.png | complex | <table><tr><td rowspan="2">Post Hoc Test (1 mL)</td><td rowspan="2">Age group (<i>i</i>)</td><td rowspan="2">Age Group (<i>j</i>)</td><td rowspan="2">Mean Difference (μ<i><sub>i</sub></i> − μ<i><sub>j</sub></i>)</td><td colspan="2">95% Confidence Interval</td></tr><tr><td>Lower</td><td>Upper</td></tr><t... |
0560b68fc3e907f3b0ab1e438c45edb6ba05434382f623932635506ea50f3eeb.png | complex | <table><tr><td>Variable</td><td>ALSPAC n (%)(N=6768)</td><td>Pelotas n (%)(N=3508)</td><td>χ<sup>2</sup></td></tr><tr><td colspan="4">Exposures</td></tr><tr><td> Low birth weight</td><td>238 (3.5)</td><td>274 (7.8)</td><td>89.99**</td></tr><tr><td> SGA</td><td>512 (7.6)</td><td>496 (14.2)</td><td>113.19**</td></tr... |
7d957e598a95d7010dfc705d5b42f4fdb0c7f9f9c0ac0158b39826db54a2e372.png | simple | <table><tr><td></td><td>Histopathological score</td><td></td><td></td></tr><tr><td></td><td>Day 7</td><td>Day 21</td><td>Day 35</td></tr><tr><td>Gb</td><td>2(1-2)</td><td>6(5-7)</td><td>8,5(7-10)</td></tr><tr><td>C</td><td>2(1-2)</td><td>5(4-6)</td><td>6(6-7)</td></tr><tr><td>p</td><td>0,535</td><td>0,009*</td><td>0,00... |
b4f209366490f439e916f653e885ac45dc201668c39fcf71553f5d54b0837dab.png | complex | <table><tr><td rowspan="2">Systemic organ class and preferred term<sup>a</sup></td><td colspan="2">Total (<i>N</i> = 209)</td></tr><tr><td>Number of Subjects (%)</td><td>Number of Adverse Events</td></tr><tr><td colspan="3">Resistance mechanism disorders</td></tr><tr><td> Infection susceptibility increased</td><td>1 (0... |
633adc2003522ca566a40b37a5f22a2f81297b6bee44f2f1f9dd5124677dbab9.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Category</td><td>IIR</td><td>Non- IIR</td><td>Total</td></tr><tr><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td>Age</td><td>≥ 35 years</td><td>31 (38.3)</td><td>31 (38.3)</td><td>62 (38.3)</td></tr><tr><td>Marital status</td><td>... |
a5e345fd37dd238b8f174b92561039c6bc603505bad4ec2d70a0c7093ef71f96.png | simple | <table><tr><td>ID</td><td>Study</td><td>IQC</td><td>EQC</td><td>CQCg</td><td>CQCp</td><td>AQCg</td><td>AQCp</td><td>SMR</td><td>Quality</td></tr><tr><td>1</td><td>GSE43264</td><td>4.02</td><td>4</td><td>2.51</td><td>3.32</td><td>2.63</td><td>4.54</td><td>2.67</td><td>high</td></tr><tr><td>2</td><td>GSE48301_eSF</td><td... |
b7d63750bb0e9784ddf9336a9fcd918a62ad453fd97d29edc0848c1db7d4a969.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">Univariable</td><td colspan="2">Multivariable</td></tr><tr><td>HR (95% CI)</td><td><i>P</i></td><td>HR (95% CI)</td><td><i>P</i></td></tr><tr><td>Age (≤54/>54)</td><td>1.698 (0.860–3.354)</td><td>0.127</td><td></td><td></td></tr><tr><td>Gender (F/M... |
277d7aac02dc1b79c8c35cf73cbd14dad12b4efbab0cb9393316c4dee0735d4e.png | complex | <table><tr><td></td><td>Parent, <i>N</i> = 100/217</td><td>Child, <i>N</i> = 63/130</td></tr><tr><td>Missing values (1st–3rd quartiles)</td><td>No missing values</td><td>No missing values</td></tr><tr><td>Response pattern</td><td>PF and HRQoL positively skewed</td><td>PF and HRQoL positively skewed</td></tr><tr><... |
4c2da8a8a8c57b298f97601aea9fe745c20be56afb969de1c93a48c046ac98e1.png | complex | <table><tr><td></td><td colspan="3"><i>n</i> (%) of sites</td></tr><tr><td></td><td>Dacron (<i>N</i> = 38<sup>b</sup>)</td><td>PTFE (<i>N</i> = 19<sup>b</sup>)</td><td>Any material (<i>N</i> = 57<sup>b</sup>)</td></tr><tr><td colspan="4">Bleeding<sup>a</sup> at 0 min</td></tr><tr><td>“No bleeding”</td><td>3... |
13dfe521296df7fa05b3256b8b83bbd296979b235b7721ed57f5d1ba1021f733.png | complex | <table><tr><td></td><td colspan="3">Fraction in state (f)</td><td>z<sub>2t</sub></td><td colspan="4">Rates of transfer (Eqs. (20)–(21))</td></tr><tr><td>Time</td><td>U</td><td>J</td><td>A</td><td></td><td><i>m</i><sub>UJ</sub></td><td><i>m</i><sub>JU</sub></td><td><i>m</i><sub>JA</sub></td><td><i>m</i><sub>AJ</su... |
22e89c02e27d163cde0028fa562cb4f415e9fb6b68dd99b7ab1221cdb5606fd8.png | complex | <table><tr><td>Variable</td><td>N</td><td>%</td></tr><tr><td colspan="3"><i>Child’s gender</i></td></tr><tr><td>Male</td><td>232</td><td>48.54</td></tr><tr><td>Female</td><td>246</td><td>52.46</td></tr><tr><td colspan="3"><i>Child’s age (months)</i></td></tr><tr><td>12–35</td><td>186</td><td>38.91</td... |
964e522bced69f89d6f6c8e189e6e9b58b2cb17039b55c178bfd7ea803ba7087.png | complex | <table><tr><td colspan="5">Box D. Content validity (including face validity)</td></tr><tr><td colspan="2"><i>General requirements</i></td><td>yes</td><td>no</td><td>?</td></tr><tr><td>1</td><td>Was assessed if all items refer to relevant aspects of the construct to be measured?</td><td>□</td><td>□</td><td>&... |
4105867cb645b53ed2e2c5e2d0b3a5ed8acdc2c0b7c54a220037ffac017649ed.png | simple | <table><tr><td></td><td>Single cellular RNA sample</td><td>Pooled RNA sample</td><td>Pooled DNA sample</td></tr><tr><td>TNF-α</td><td>95</td><td>95</td><td>100</td></tr><tr><td>β2-MG</td><td>90</td><td>90</td><td>100</td></tr><tr><td>MIF</td><td>88</td><td>88</td><td>100</td></tr><tr><td>UBC</td><td>81</td><t... |
84c8014a7543ba13b5894da15608468b8b4c5731816a896bf53098368adb6334.png | complex | <table><tr><td rowspan="2"></td><td>Total <i>n</i> = 1645</td><td>non-JIA <i>n</i> = 1316</td><td>JIA <i>n</i> = 329</td><td></td></tr><tr><td><i>n</i> %</td><td><i>n</i> %</td><td><i>n</i> %</td><td><i>P</i>-value</td></tr><tr><td>Age (year), mean ± SD<sup>a</sup></td><td>11.3 ± 3.47</td><td>11.3 ± 3.47... |
8563bda3f8b8b277dbe27c0b23a2a4e335b1fda2e9532282996d1ec70add75cb.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">cn/cn</td><td colspan="3">cn/+</td></tr><tr><td>Growth plates studied</td><td># Histologic sections</td><td>Range of # of sections per growth plate</td><td>Growth plates studied</td><td># Histologic sections</td><td>Range of # of sections per growth plate</td></tr><tr><td... |
ad22a0feeee4c72b94078e88f31aec3a1861aafda486b24a981d629fa31442c8.png | complex | <table><tr><td colspan="2"></td><td>Homicides (per 100,000)</td><td>DALY (thousands)</td></tr><tr><td colspan="2">World</td><td>7.9</td><td>21,701,428</td></tr><tr><td colspan="2">High income countries</td><td>2.7</td><td>886,297</td></tr><tr><td rowspan="6">Low–middle income countries</td><td>Africa</td><td>20.1... |
73cc8244051bf2aa3d890c9e1f711fb82c5e92887d897b597c27cfa20cfd51f3.png | complex | <table><tr><td rowspan="2">Gene</td><td colspan="2">Fraction of <i>est2∆ rad51∆ xxx∆</i> that are able to form survivors</td><td rowspan="2">Reference</td></tr><tr><td>in BY4741 background<i><sup>a</sup></i></td><td>in W303 background</td></tr><tr><td><i>CCR4</i><i><sup>b</sup></i></td><td></td><td>0/... |
7579a10b0761bd239950113d71845deedda1a85dd9e8f87f631417670d05f90f.png | complex | <table><tr><td></td><td colspan="7">Parity</td></tr><tr><td>Measurements</td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6 or later</td></tr><tr><td>Number of serviced records</td><td>93,604</td><td>78,243</td><td>70,596</td><td>62,258</td><td>53,371</td><td>43,634</td><td>52,352</td></tr><tr><td>Nu... |
4201751865a366a73f50c1598b6c856f75d34b3770ceb1116299faaed94945de.png | simple | <table><tr><td>Kidney cancer dataset</td><td>CANOVA</td><td>Kendall</td><td>Pearson</td><td>Spearman</td><td>Hoeffding</td><td>Distance</td><td>MIC</td></tr><tr><td>Significant gene number</td><td>5901</td><td>11569</td><td>8239</td><td>11629</td><td>4953</td><td>10946</td><td>8081</td></tr><tr><td>Computing time (seco... |
fe90ee019ad0e3f5e6ea67eb798a19b18b3beca6a467f525016c89ea031c1bbe.png | simple | <table><tr><td>Article</td><td>Number (M/F)<sup>1</sup></td><td>C/R/R-S<sup>2</sup></td><td>Age Mean ± SD<sup>3</sup>/Median (range)</td><td>ST<sup>4</sup></td><td>Cut-off</td><td>Rate(+)<sup>5</sup></td><td>Follow up Mean ± SD/Median (range)</td><td>OM<sup>6</sup></td><td>Surgery</td><td>MA<sup>7</sup></td><... |
9cea7c1dcc75bee28acca0f18898512416b6c9898e8435191b7fb6a1b7f39664.png | simple | <table><tr><td>Biomolecule</td><td>Molecular weight (kDa)</td><td>Isoelectric point</td><td>Charge</td><td>Hydrodynamic radius (Å)</td><td>Amount (μg)</td></tr><tr><td>AcSDKP peptide</td><td>0.4</td><td>5.5</td><td>Negative</td><td>7<sup>a</sup></td><td>1000</td></tr><tr><td>Insulin</td><td>5.73</td><td>5.3<... |
05df35fd3cb6e167b0b2597e7edb7ebccd0c08aae4ef304d3bf20e52bd1a91dc.png | simple | <table><tr><td>Delivery system</td><td>Diameter (mm)</td><td>Headspace (ml)</td><td>Milk-to-air interface (cm<sup>2</sup>)</td></tr><tr><td>Gerber (G)</td><td>52</td><td>176</td><td>21.23</td></tr><tr><td>Ventaire (V)</td><td>54</td><td>183</td><td>22.89</td></tr><tr><td>Dr. Brown's (DB)</td><td>50</td><td>66*</td><td>... |
688fcf8fff88d85403b3a87cad259fb7bd8ef65414b7f5e0ccc8af021f60a8db.png | complex | <table><tr><td colspan="4">Medium scale construction sites</td></tr><tr><td>Site</td><td>Total (max. = 120)</td><td>Mean</td><td>Correlation coefficient</td></tr><tr><td>1</td><td>58</td><td>4.83</td><td>0.56</td></tr><tr><td>2</td><td>48</td><td>4.00</td><td>−0.22</td></tr><tr><td>3</td><td>50</td><td>4.17</td><... |
17f0e45152d67e9e521daa569b7e0dc79d2d9c24142a23c2e5b73d30f665b1fe.png | simple | <table><tr><td>Dataset</td><td>Nematode hits </td><td>Trematode hits </td><td>Cestode hits </td></tr><tr><td><i>C. elegans </i>proteins (Wormpep)</td><td>8457</td><td>345</td><td>280</td></tr><tr><td><i>S. mansoni </i>proteins</td><td>3440</td><td>598</td><td>419</td></tr><tr><td>Human proteins</td><td>4539</td><td>408... |
39462305c108655fc7de9e8950594a52417cfcdc39122c472519f1367636e3fd.png | complex | <table><tr><td>Variables</td><td></td><td>Frequency</td><td>Percent</td></tr><tr><td rowspan="2">Abdomen palpated to rule out the presence of second baby</td><td>Yes</td><td>331</td><td>62.7</td></tr><tr><td>No</td><td>197</td><td>37.3</td></tr><tr><td rowspan="4">Uterotonic drugs given</td><td>Oxytocin</td><td>432</td... |
a35c170936ee5639cea34c5d5c562b3ed537c55511a61e66e199aa39b4dd3d4b.png | complex | <table><tr><td>Cutoff</td><td>Results</td><td>African population<i>N</i> (%)</td><td>Caucasian population<i>N</i> (%)</td><td><i>p</i></td></tr><tr><td rowspan="2">AR ≥ 1%</td><td>Negative</td><td>22 (33.8)</td><td>22 (16.9)</td><td></td></tr><tr><td>Positive</td><td>43 (66.2)</td><td>108 (83.1)</td><td>0.008</td... |
79cbc6e09c3de35e399ac3fd8dc9312ef2ebfc25e2e63ec1c7c60d426dcec33f.png | simple | <table><tr><td>Species</td><td>Title of publication</td><td>cDNAs used for reprogramming</td><td>Origin of cDNAs</td></tr><tr><td>Rhesus macaque (<i>Macaca mulatta</i>)</td><td>Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts [24]</td><td><i>POU5F1, SOX2 KLF4</i> and <i>MYC </i></td><td... |
7cc8a2688bb7dd9b857025034048d4a4965777d0d6725017be0c2ffaf6aca49e.png | simple | <table><tr><td>Age</td><td>Sex</td><td>Cause of death</td></tr><tr><td>60</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>56</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>25</td><td>M</td><td>Traumatic brain injury</td></tr><tr><td>40</td><td>F</td><td>Hemorrhagic stroke</td></tr><tr><td>50</td><td>F</td>... |
ee8b4497dd2e6bb9c23550929b6e0cdb8522c4ce1ec218c5eb9c116dd1f7d508.png | complex | <table><tr><td></td><td>Respimat® 5 μg</td><td>HandiHaler® 18 μg</td><td>Placebo</td></tr><tr><td colspan="4">Average heart rate (BPM), mean ± SD (min–max)</td></tr><tr><td colspan="4"> <i>Study 205.284</i></td></tr><tr><td>Baseline</td><td>–</td><td>79.89 ± 10.88 (59–108... |
b1b9d46699a492b115a349ee3a417f9686f3494723449b188b3224d3442f40ca.png | complex | <table><tr><td>Predictor</td><td><i>B</i></td><td><i>SE</i></td><td><i>t</i></td></tr><tr><td colspan="4">MEDIATOR—PERCEPTIONS OF INJUSTICE</td></tr><tr><td>Control: Negative affectivity</td><td>0.13</td><td>0.02</td><td>8.27<sup>***</sup></td></tr><tr><td>Predictor: Observed incivility toward women</td><td>0.61<... |
f4703a7cc0a64e9bbf758c31560b7070c9cff8d37f8cd788c0ee07b0976efeea.png | complex | <table><tr><td>Rat strains</td><td colspan="2">WKY</td><td colspan="2">SHR</td><td colspan="2">SHRSP5/Dmcr</td></tr><tr><td></td><td>Control</td><td>HFC</td><td>Control</td><td>HFC</td><td>Control</td><td>HFC</td></tr><tr><td>Body weight (g)</td><td>365 ± 22.6</td><td>331 ± 7.8 <sup>a</sup></td><td>339 ±... |
e989b33c4d13f94d02434bbc584f3373a99944eb02acfdd65938e923f21da48f.png | simple | <table><tr><td>Source</td><td>Patients</td><td>Inclusion criteria</td><td>Antioxidant agent</td><td>Dose</td><td>Route</td><td>Endpoints</td><td>Followup</td><td>Events</td></tr><tr><td>CHAOS [106]</td><td>2002</td><td>Angiographically demonstrated CAD</td><td>Vit E</td><td>400/800 IU</td><td>PO</td><td>CV death + MI; ... |
3deb7c19e964369795e70997cf9c0332ca2acab34ec1e63d834fa62a5b978d89.png | simple | <table><tr><td>Language version ofsurvey</td><td>Responses</td></tr><tr><td>English</td><td>17785</td></tr><tr><td>Spanish</td><td>1052</td></tr><tr><td>French</td><td>955</td></tr><tr><td>Russian</td><td>330</td></tr><tr><td>Chinese</td><td>265</td></tr><tr><td>Japanese</td><td>258</td></tr><tr><td>Arabic</td><td>18</... |
8d1e0a5834a586ff841c9b7f54c845c82766fb2a168fee98bd55c418ac9dcdd7.png | simple | <table><tr><td> </td><td>Correlation coefficient (<i>r</i>)</td><td><i>P</i> value</td></tr><tr><td>Tissue estriol-tissue OxLDL</td><td>0.36</td><td> 0.004</td></tr><tr><td>Tissue estriol-GW</td><td>0.25</td><td> >0.05</td></tr><tr><td>Tissue OxLDL-GW</td><td>0.04</td><td> >0.05</td></tr><tr><td>Tissue estriol-in... |
0bbfc63d1bae84c537315c893d7afae66d3d90af5e9c4d6e5b3c88a0cec21754.png | simple | <table><tr><td>Strain No.</td><td>SGSC No.</td><td>PCR results</td></tr><tr><td>RKS4587</td><td>2289</td><td>-</td></tr><tr><td>RKS4620</td><td>2291</td><td>-</td></tr><tr><td>33K</td><td>2419</td><td>-</td></tr><tr><td>CN13/87</td><td>2712</td><td>-</td></tr><tr><td>RKS4585</td><td>2998</td><td>+</td></tr><tr><td>RKS4... |
cd0a8b8a02756338c1c1c3595927cc59ddc51f433d191580569cdedbc7baec0b.png | simple | <table><tr><td>Variable</td><td>N</td><td>Median</td><td>Mean</td><td>SD</td></tr><tr><td>Programs offering residential treatment*</td><td></td><td></td><td></td><td></td></tr><tr><td> Average daily client census</td><td>49</td><td>26.0</td><td>43.4</td><td>59.0</td></tr><tr><td> Client occupancy ratio (%)<sup>†<... |
eb4559f6bc6bdc028cc6f336dd0e6abe81ffe2868bf47785b81cecd0ef91e746.png | simple | <table><tr><td>Subject No.<sup>a</sup></td><td>Sex (age)<sup>c</sup></td><td>CD4 Count (cells/μl)</td><td>CD8 Count (cells/μl)</td><td>Plasma Viral Load (copies/ml)</td><td>HCV<sup>b</sup></td><td>HBV<sup>b</sup></td><td>HIV Subtype</td></tr><tr><td>1</td><td>M(42)</td><td>332</td><td>1326</td><td>18800</td><... |
199b093abc2020d4a9729cd553070b6f0e10493b2215a02e2486a86b1860130b.png | complex | <table><tr><td rowspan="2">COX4 Expression</td><td colspan="4">Hsp60 Expression</td><td rowspan="2">Total, N</td></tr><tr><td>-</td><td>+</td><td>++</td><td>+++</td></tr><tr><td>-</td><td>11</td><td>15</td><td>5</td><td>0</td><td>31</td></tr><tr><td>+</td><td>8</td><td>36</td><td>29</td><td>37</td><td>110</td></tr><tr>... |
cdda26b1942494e93a9ea6c8abf238575afd0ffe52da0cce26e1bc13b6926673.png | simple | <table><tr><td>Name</td><td>Fold Change (T/N)</td><td>log2Fold Change(T/N)</td><td><i>P</i> Value</td><td>FDR</td></tr><tr><td>hsa-mir-210</td><td>31.74</td><td>4.99</td><td>2.54E-05</td><td>0.004</td></tr><tr><td>hsa-mir-183</td><td>7.22</td><td>2.85</td><td>6.03E-05</td><td>0.007</td></tr><tr><td>hsa-mir-10b</td><td>... |
83b1e00b645689b658a2e7d8746378c183c7b6eb51c440b577b1d2093712b649.png | complex | <table><tr><td>MMCO Metrics</td><td>Metrics Detail</td><td>MMCO V2.0 (Existing Work) [6]</td><td>MMCO V3.0 (Extended Work)</td></tr><tr><td rowspan="8">Metrics</td><td>Axioms</td><td>793</td><td>1092</td></tr><tr><td>Logical Axioms</td><td>624</td><td>859</td></tr><tr><td>Class count</td><td>45</td><td>225</td></tr><tr... |
53bce9d71952b908921878f063b7cd1937091240a9efeac9739d6a32610b4533.png | simple | <table><tr><td>Variables</td><td>Pretraining</td><td>Posttraining</td><td>t</td><td>p</td></tr><tr><td>Basic rhythm (left)</td><td>74.23 ± 6.84</td><td>75.07 ± 9.04</td><td>−0.189</td><td>0.856</td></tr><tr><td>Basic rhythm (right)</td><td>75.40 ± 9.70</td><td>72.85 ± 10.20</td><td>0.363</td><... |
551318c979d7522f8ecce068f116bd8e13a36a4fc1d6bc5259b2c416978dacd9.png | complex | <table><tr><td colspan="6">Canagliflozin (300 mg q.d.) and cyclosporine A (400 mg q.d.)</td></tr><tr><td rowspan="2">Parameter</td><td colspan="2">Arithmetic mean (SD)</td><td colspan="3">Geometric mean<sup>a</sup></td></tr><tr><td>Canagliflozin alone (n = 18)</td><td>Canagliflozin + cyclosporine A (n = 17)</td><td>Can... |
bd15bddfba32369388463b73fa493572c355105ad57887674bf996eaf5e5a7bb.png | complex | <table><tr><td>Collection Season</td><td colspan="4">District</td></tr><tr><td></td><td>Pampulha</td><td>North</td><td>East</td><td>All districts</td></tr><tr><td></td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td><td>IF/CF (IR%)</td></tr><tr><td>1st</td><td>14/67 (20.8)</td><td>9/22 (40.9)</td><td>3/28 (... |
ae56985ca37a236e3f20856824981db67dab10e2a0e299b496e8ef4279204b28.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">Diarrhoea</td><td colspan="2">Fever</td><td colspan="2">Cough</td></tr><tr><td>COR</td><td>AOR</td><td>COR</td><td>AOR</td><td>COR</td><td>AOR</td></tr><tr><td>Toilet facilities (yes)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><... |
a1e8f4e48b1d6f7fa511e41f06e210a0de145bc2771dd4da243f9f3af2138794.png | simple | <table><tr><td>Factor</td><td>HR</td><td>95 % confidence interval</td><td>P value</td></tr><tr><td>Acute kidney injury 3</td><td>7.35</td><td>2.15–25.07</td><td>0.001</td></tr><tr><td>Peripheral vascular disease</td><td>1.95</td><td>1.12–3.39</td><td>0.019</td></tr><tr><td>Chronic renal failure</td><td>1.59... |
21cdf96cca7f5cf2074c7ce56d8c46cea207b6a921b75d333e8f2d6ec7c710cd.png | complex | <table><tr><td></td><td colspan="2">MIC (μg/mL)</td></tr><tr><td>Formulation</td><td>MS-Lac</td><td>Estimated Gentamicin in Microspheres *</td></tr><tr><td>MS-Lac1</td><td>2.16</td><td>0.31</td></tr><tr><td>MS-Lac2</td><td>2.92</td><td>0.31</td></tr><tr><td>MS-Lac3</td><td>4.00</td><td>0.31</td></tr></table> |
538e9ee5f34c3224c2631be90703d75b1e8baa105cf4934e53f70627adeb4779.png | complex | <table><tr><td>Variable</td><td>Adjusted PR (95%CI)</td><td><i>p</i>-value<sup>a</sup></td></tr><tr><td colspan="3"><i>Housing area</i></td></tr><tr><td>Urban</td><td>1</td><td> </td></tr><tr><td>Rural</td><td>1.15 (1.0-1.3)</td><td>0.030</td></tr><tr><td colspan="3"> </td></tr><tr><td colspan="3"><i>School type</i></t... |
fd336328d6f03c11a80f820469e8165b1983af5c8b2d888a312cc09e6ad16bea.png | simple | <table><tr><td>Clinicopathological parameters</td><td>Relative risk ( 95%CI)</td><td>p value</td></tr><tr><td>Age(≥65years)</td><td>0.884(0.561-1.395)</td><td>0.597</td></tr><tr><td>Sex(Female)</td><td>0.817(0.520-1.283)</td><td>0.380</td></tr><tr><td>Depth of invasion (T<sub>2-4</sub>)</td><td>5.873(2.058-16.762... |
dde9f88a0e9195e24ecc376f6197f8585bdd12c75cc7d8d9712c84b1bce37bba.png | simple | <table><tr><td>Variable</td><td>Patients (%)</td></tr><tr><td>Gender</td><td></td></tr><tr><td> Male</td><td>74 (71.8)</td></tr><tr><td> Female</td><td>29 (28.2)</td></tr><tr><td>Age (y)</td><td></td></tr><tr><td> Mean</td><td>58.3</td></tr><tr><td> Range</td><td>26–75</td></tr><tr><td>Tumor location</td><td></td... |
8c509a01a9e2d7b09f2a6925bda74a6e9f33214a63eb8e54ff0eec4ea593b890.png | simple | <table><tr><td>Patients</td><td>n = 3191</td></tr><tr><td>Age, years</td><td>70 ± 10</td></tr><tr><td>≤65 years, %</td><td>30</td></tr><tr><td>66-79 years, %</td><td>54</td></tr><tr><td>≥80 years, %</td><td>16</td></tr><tr><td>Gender, male vs. female, %</td><td>43 vs. 57</td></tr><tr><td>BMI, kg/m<sup>... |
6eb37bfbc5d49bf05046c90b57d73a9e4113a5377a6895addcea67ccc356b506.png | simple | <table><tr><td> </td><td>Progression-free survival</td><td>Overall survival</td></tr><tr><td>AUC (95% CIs)</td><td>0.71 (0.57–0.83)</td><td>0.65 (0.50–0.78)</td></tr><tr><td>Criterion (cut-off)</td><td>≥19%</td><td>≥13%</td></tr><tr><td>Sensitivity</td><td>73%</td><td>58%</td></tr><tr><td>Specif... |
d7b950d8e878af7b386e539fd036b4ba778120703c992f7889a28e3d8fdcb2c4.png | complex | <table><tr><td rowspan="3">Run</td><td colspan="6">Parameters</td><td colspan="2">HPR (ml H<sub>2</sub>/L h)</td></tr><tr><td colspan="2">Initial pH (<i>X</i><sub>1</sub>)</td><td colspan="2">Light intensity (<i>X</i><sub>2</sub>)</td><td colspan="2">Mo concentration (<i>X</i><sub>3</sub>)</td><td rowspan="2">Observed<... |
0d8680db68e2ae7a7cc371c929b7e27e8a32b9dc5c4a34b0da54c97624aeeea2.png | complex | <table><tr><td>Patient characteristics</td><td>Value</td></tr><tr><td>Age (years), median (IQR)</td><td>38.0 (29.0–43.0)</td></tr><tr><td colspan="2">Sex, <i>n</i> (%)</td></tr><tr><td> Female</td><td>13 (68.4)</td></tr><tr><td> Male</td><td>6 (31.6)</td></tr><tr><td colspan="2">Race, <i>n</i> (%)</td></tr><tr><t... |
f0958074927e3ed747b9ae853e17889050f15ee24411412bf967f4f12acba006.png | complex | <table><tr><td></td><td colspan="5">Inpatient hospital contact (1987–2012)</td><td colspan="5">Any hospital contact (2001–2012)</td></tr><tr><td></td><td colspan="2">No bereavement</td><td colspan="3">Bereavement</td><td colspan="2">No bereavement</td><td colspan="3">Bereavement</td></tr><tr><td></td><td>N<... |
1414d8411c051cc88e93471a16972aa5a39a7386744d6b346ec90c0095bd499b.png | simple | <table><tr><td>No.</td><td>IUPAC Name</td></tr><tr><td>BDE-209</td><td>Deca-bromodiphenyl ether</td></tr><tr><td>BDE-208</td><td>2,2',3,3',4,5,5',6, 6'- nona-bromodiphenyl ether</td></tr><tr><td>BDE-207</td><td>2,2',3,3',4,4',5,6,6'-nona-bromodiphenyl ether</td></tr><tr><td>BDE-206</td><td>2,2',3,3',4,4',5,5',6-nona-br... |
fb1505b0f1f1112c759282ec93397d63051e7b6a6e6f773270d7b8caad42eff8.png | simple | <table><tr><td></td><td>Appearance</td></tr><tr><td>Rich looking/smart/elegant</td><td>Liked the colors</td></tr><tr><td>Different</td><td>Simple/neat</td></tr><tr><td>Looks cold/refreshing/clean</td><td>Eye-catching/bold</td></tr><tr><td>Bright</td><td>Attractive</td></tr><tr><td>Happy</td><td>Modern and up-to-date</t... |
0d2354a290d68441aff09411f8a7b2de1a8b9bc9711cf8aec412a74598189839.png | simple | <table><tr><td>Variable</td><td>Baseline (2004)</td><td>5-year follow-up (2009)</td><td>P-value<sup>a</sup></td></tr><tr><td>Age, mean (SD)</td><td>43.6 (9.5)</td><td>48.6 (9.5)</td><td></td></tr><tr><td>SMBQ score, mean (SD)</td><td>2.86 (0.91)</td><td>2.71 (1.05)</td><td><0.001</td></tr><tr><td>SMBQ score > 4.0... |
7de9a028338bd4d9ddb838e0ccdf7b0302b0aaa73337a7efa6c358617d9ed598.png | complex | <table><tr><td></td><td colspan="3">Prior to 1:1 matching</td><td colspan="3">After 1:1 matching<sup>*</sup></td></tr><tr><td>Variables</td><td>Vulvar cancer patients</td><td>Controls</td><td><i>P</i>-value<sup>*</sup></td><td>Vulvar cancer patients</td><td>Controls</td><td><i>P</i>-value<sup>*</sup></td></tr><tr><td>N... |
ad96958877aba67ee3bf20beb974606fecc3f49a360be0dc9bd01b8efd28c4b7.png | simple | <table><tr><td></td><td>Arm A IRI+LV+5FU</td><td>Arm B LV+5FU</td><td><i>P </i>(log-rank)</td></tr><tr><td>Disease-free survival (DFS)</td><td></td><td></td><td>0.436</td></tr><tr><td> Progressions, <i>n (%)</i></td><td>110 (24.9)</td><td>112 (25.9)</td><td></td></tr><tr><td> Median (months)</td><td>Not reached yet</td... |
dda653adc92487b365e871ef74f69bdbef5c96192a74af8a7daadec8bc4c96b0.png | complex | <table><tr><td>Deliveries in six months</td><td colspan="2">Total number %</td><td colspan="2">Without malformation number %</td><td colspan="2">With malformation number %</td></tr><tr><td>Ayder referral hospital</td><td>503**</td><td>33</td><td>484</td><td>32</td><td>19</td><td>3.8</td></tr><tr><td>Mekelle hospital</t... |
c70088f31f802d5f2fe232c57c2136f84c5fb2e22d2a288c625bd01684a662ba.png | simple | <table><tr><td></td><td>ypN0</td><td>ypN1</td><td>ypN2</td><td>Total</td></tr><tr><td>yN0</td><td>41</td><td>-</td><td>-</td><td>41 (66.1)</td></tr><tr><td>yN+</td><td>7</td><td>11</td><td>3</td><td>21 (33.9)</td></tr><tr><td>Total</td><td>48 (77.4)</td><td>11 (17.8)</td><td>3 (4.8)</td><td>62 (100)</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.